BOSTON, Oct. 4, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the tuck-in acquisition of Altar, a French biotechnology company ...

The synthetic biology company Ginkgo Bioworks announced the acquisition of two companies: French-based Altar and Circularis, located in Oakland, CA. The news comes just months after Ginkgo’s largest ...

Ginkgo Bioworks, the Boston-based synthetic biology company, said Tuesday that it has acquired two biotech companies, Altar and Circularis. Terms of the deals were not disclosed. Atlas has fewer than ...

Ginkgo Bioworks Holdings Inc DNA shares are trading higher Tuesday after the company announced the acquisitions of Altar and Circularis. Terms of the deals were not disclosed. Altar is a French ...